专业资本入主 莱茵生物拟收购食品科技企业金康普

Core Viewpoint - Rhein Biotech, a leader in the plant extraction industry, is undergoing a significant change in control and asset acquisition, led by Defu Capital, which manages over $34 billion in funds, aiming to inject strong growth momentum into the company [1][2]. Group 1: Company Overview - Rhein Biotech has over 300 standardized plant extraction technologies and has established multiple national-level research platforms, including a "National Tropical Fruit Processing Technology R&D Center" and a "Postdoctoral Research Station" [1]. - The company holds a stable global market share of 20%-25% in monk fruit extract and ranks among the top three globally in stevia extract sales [1]. Group 2: Capital Cooperation - Defu Capital, a seasoned investment institution in the healthcare and consumer sectors, is acquiring control through its Guangzhou Defu Nutrition Investment platform, with 99.926% of the investment coming from its core operating entity, reflecting strong confidence in Rhein Biotech's future [2]. - The acquisition includes Beijing Jinkangpu Food Technology Co., a leading company in the food premix sector, which has three modern production bases and a capacity of over 10,000 tons [2]. Group 3: Strategic Synergy - The collaboration between Rhein Biotech and Jinkangpu is expected to create a robust industrial ecosystem, where Rhein's natural raw materials will supply Jinkangpu's production system, ensuring quality raw materials for end products [2]. - Jinkangpu's strong customer base and international channels will open new markets for Rhein's high-value products, enhancing product value significantly [2]. Group 4: Future Prospects - The partnership is anticipated to accelerate the transformation of technology for Rhein Biotech, integrating its R&D capabilities with Jinkangpu's application strengths in food and health products [3]. - As consumer demand for "natural health" continues to rise, this strategic alliance is expected to further solidify Rhein Biotech's leading position in the global natural health products market [3].

Layn-专业资本入主 莱茵生物拟收购食品科技企业金康普 - Reportify